Drugs Made In America Acquisition Corp. (DMAA) stock
DMAANasdaqBlank ChecksFiscal year ends December 31Also trades as DMAAR, DMAAU
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026
$10.90+0.00 (0.00%)
Close on Nov 17, 2026Market cap $264.62MP/E –Yield –
Drugs Made In America Acquisition price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
No price to sales ratio figures for Drugs Made In America Acquisition
Drugs Made In America Acquisition has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?